Condition
Brain Metastases, Adult clinical trials and research
As of November 12, 2026, Find a Trial lists 23 Brain Metastases, Adult clinical trials that are recruiting, at sites in 11 countries (most in United States (11), Netherlands (2), Italy (2)). By phase: Phase 2 (9), Phase 1 (2), Phase 1/2 (1). The most active sponsors are Maastricht University Medical Center (2), University of Vermont Medical Center (2), Baptist Health South Florida (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 11Countries
Newest Brain Metastases, Adult clinical trials
All recruiting trials (23)
-
Tarlatamab for Small Cell Lung Cancer with Brain Metastases
This phase II study tests whether tarlatamab can help adults with small cell lung cancer that has spread to the brain, by treating both systemic disease and brain tumors.
-
AI-assisted diagnosis for malignant brain tumors
This project will test an AI system that uses routine preoperative MRI scans to automatically segment and classify malignant brain tumors in adults to help guide diagnosis and care.
-
Same-day stereotactic radiation with reduced planning margins for growing or changing brain metastases
This trial will try to see if doing MRI planning and stereotactic radiation on the same day, with either a 0 mm or 1 mm treatment margin, helps adults with growing or unstable brain metastases stay on target and reduce side effects.
-
Preventing first seizures with levetiracetam in patients with motor cortex brain metastases
This test will try giving levetiracetam to adults with motor cortex brain metastases who have never had a seizure to see if it prevents a first seizure compared with not giving the drug.
-
Avoiding brain radiation when systemic therapy already targets brain metastases
This pilot trial tests whether patients with brain metastases who respond to systemic therapy can skip brain radiation.
-
Using ex vivo pharmacoscopy to guide treatment for brain metastases
This project will test whether pharmacoscopy, a lab test that screens a patient's tumor cells against many drugs, can help pick effective treatments for adults having surgery for brain metastases.
-
DE-iPTV radiotherapy for breast cancer that has spread to the brain in patients not eligible for SRS
This trial tests a dose-escalated internal PTV radiotherapy approach (DE-iPTV) for adults with breast cancer brain metastases who can’t have stereotactic radiotherapy, to see if it can be delivered safely and whether it improves quality of life.
-
Investigating genetic similarities between primary colorectal tumors and their brain metastases
This study is looking at the genetic similarities between original colorectal cancer tumors and their brain metastases to see how closely they match in terms of important gene mutations.
-
Combining sacituzumab govitecan and bevacizumab for treating brain metastases in lung cancer
This study is testing if a combination of two drugs, sacituzumab govitecan and bevacizumab, can help shrink brain tumors in patients with lung cancer who haven't responded to other treatments.
-
Intensive multi-disciplinary care for patients with brain metastases
This study is testing if a team-based approach to care for patients with newly diagnosed brain metastases can help them feel better and understand their condition more clearly compared to standard care.
-
Feasibility of advanced stereotactic radiotherapy for brain metastases
This study is testing a new type of precise radiation treatment for patients with brain metastases to see if it can control tumors better and improve their quality of life compared to standard methods.
-
Evaluating brain metastasis treatment using PET imaging
This study is testing if a special type of brain scan can help doctors see how well treatment is working for patients with brain tumors caused by cancer.
-
Testing NEO212 for treating certain brain tumors and metastases
This study is testing a new treatment called NEO212 for people with certain types of brain tumors to see if it is safe and effective when combined with standard treatments.
-
Using silibinin to prevent brain metastasis recurrence in lung and breast cancer patients
This study is testing if a medication called silibinin can help prevent brain cancer from coming back in patients who have had surgery for lung or breast cancer.
-
New MRI technique to assess brain tumors after treatment
This study is testing a new MRI method to see if it can tell the difference between real tumor growth and changes caused by treatment in people with brain tumors.
-
Comparing preoperative and postoperative hypofractionated radiosurgery for large brain metastases
This study tests whether giving targeted radiation before or after surgery helps people with large brain tumors do better and have fewer side effects.
-
Collection of blood samples from adults with brain tumors
This study is collecting blood samples from adults with brain tumors to see if certain markers in the blood can help improve treatment outcomes after radiation therapy.
-
Stereotactic radiosurgery for lung cancer that has spread to the brain
This study is testing if a targeted radiation treatment can help people with small cell lung cancer that has spread to their brain feel better and improve their outcomes.
-
Comparing preoperative and postoperative radiation for brain metastases
This study tests if giving radiation before surgery for brain metastases can lower the chance of cancer spreading in the brain compared to giving it after surgery.
-
Neurocognitive assessment in patients with brain oligometastases receiving targeted radiotherapy
This study is testing if a new type of targeted radiation therapy can help people with brain oligometastases keep their thinking skills better than the usual whole-brain radiation.
-
Using 18F-Fluciclovine to Monitor Brain Metastases After Radiation Therapy
This study is testing a new imaging agent called 18F-fluciclovine to see if it can help track how well radiation therapy is working for people with large brain metastases.
-
Cognitive-sparing radiosurgery for brain metastases
This study is testing a new way to use targeted radiation for patients with brain tumors to see if it can help protect their thinking skills while treating the cancer.
-
Using brain imaging to predict treatment response in patients with brain metastases
This study is testing if brain scans can help predict how well patients with brain metastases will respond to radiation treatment.
Related topics
Quick answers
How many Brain Metastases, Adult clinical trials are recruiting right now?
23, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (11 trials), Netherlands (2 trials), Italy (2 trials), Switzerland (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 9, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.